Chun Byung-Joon, Bae Ja-Sung, Chae Byung-Joo, Park Jun-Ook, Nam Inn-Chul, Kim Chung-Soo, Cho Kwang-Jae, Hwang Yeon-Shin, Shim Mi-Ran, Park Young-Hak, Sun Dong-Il
Department of Otolaryngology-Head and Neck Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 137-701, Korea.
Eur Arch Otorhinolaryngol. 2015 Mar;272(3):727-36. doi: 10.1007/s00405-014-3021-7. Epub 2014 Apr 2.
The objective of this study was to investigate the efficacy of early management of post-thyroidectomy unilateral vocal cord palsy (UVCP) and the clinical utility of the thyroidectomy-related voice questionnaire (TVQ) when planning UVCP treatment. The study group comprised 48 consecutive patients diagnosed with UVCP after thyroidectomy. Laryngoscopic examination and voice analysis were conducted, and the TVQ was administered pre-thyroidectomy and at 2 weeks and 1, 3, 6, and 12 months post-thyroidectomy. Twenty-five patients with aspiration symptoms and severe vocal difficulties received injection laryngoplasty, and 23 with no aspiration symptoms and relatively mild vocal difficulties underwent voice therapy. We performed a video fluoroscopic swallowing study on each patient 2 weeks after thyroidectomy and 1 month following the procedure. The average total TVQ scores 2 weeks post-thyroidectomy were 51.92 ± 11.42 in the injection laryngoplasty group and 35.78 ± 12.99 in the voice therapy group. Both subjective and objective parameters improved significantly at 1 month after treatment and continued to improve slowly over the next 12 months (p < 0.01) in both groups. TVQ scores were significantly lower in the injection laryngoplasty group than in the voice therapy group 1 month post-intervention (p < 0.01). At the study end point, the greatest improvement in subjective symptoms occurred in temporary VCP patients who underwent injection laryngoplasty. The optimal TVQ score cut-off distinguishing the two groups was 45 (68.0 % sensitivity, 78.3 % specificity). In conclusion, early management following timely diagnosis of post-thyroidectomy UVCP can improve symptoms within 1 month. Moreover, application of TVQ will aid clinicians to plan treatment for postoperative VCP patients.
本研究的目的是探讨甲状腺切除术后单侧声带麻痹(UVCP)早期治疗的疗效,以及在规划UVCP治疗时甲状腺切除相关嗓音问卷(TVQ)的临床应用价值。研究组包括48例甲状腺切除术后连续诊断为UVCP的患者。进行了喉镜检查和嗓音分析,并在甲状腺切除术前、术后2周以及术后1、3、6和12个月进行了TVQ问卷调查。25例有呛咳症状和严重嗓音困难的患者接受了注射喉成形术,23例无呛咳症状且嗓音困难相对较轻的患者接受了嗓音治疗。我们在甲状腺切除术后2周和术后1个月对每位患者进行了电视透视吞咽研究。注射喉成形术组甲状腺切除术后2周的TVQ总平均分是51.92±11.42,嗓音治疗组是35.78±12.99。两组在治疗后1个月主观和客观参数均显著改善,并在接下来的12个月中继续缓慢改善(p<0.01)。干预后1个月,注射喉成形术组的TVQ评分显著低于嗓音治疗组(p<0.01)。在研究终点,主观症状改善最明显的是接受注射喉成形术的暂时性VCP患者。区分两组的最佳TVQ评分临界值为45(灵敏度68.0%,特异度78.3%)。总之,甲状腺切除术后UVCP及时诊断后的早期治疗可在1个月内改善症状。此外,TVQ的应用将有助于临床医生为术后VCP患者规划治疗方案。